GUIDE: Reporting Template_HIV

Similar documents
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

World Health Organization. A Sustainable Health Sector

M&E for Accountability & Global Progress Tracking

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

By 20 February 2018 (midnight South African time). Proposals received after the date and time will not be accepted for consideration.

Harm Reduction in Nigeria

United Nations Office on Drugs and Crime (UNODC)

TARGET INTERVENTION (SIMS Reporting Indicator Definitions)

SCALING UP TOWARDS UNIVERSAL ACCESS

Technical Guidance Note for Global Fund HIV Proposals

As a result of this training, participants will be able to:

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

LOGFRAME FOR LESOTHO

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

Health Promotion Service Project Overview 08/09

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

Viral Hepatitis. WHO Regional Office for Europe July 2013

Global reporting system for hepatitis (GRSH) project description

Prevention targets & scorecard

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

NATIONAL PROGRAMME ON THE RESPONSE TO THE HIV EPIDEMIC

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

:1/5 (B), Sayarsan Road, Bahan, Yangon Contact No. :

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

UNGASS COUNTRY PROGRESS REPORT Republic of Armenia

Gender Mainstreaming in the Convention on Biological Diversity

United Nations Development Programme (UNDP) Sudan. Grant Closure Plan HIV Round 5 Global Fund Grant Grant Number: SUD-506-G08-H. Sudan.

As a result of this training, participants will be able to:

UNGASS Country Progress Report. Myanmar

END TERM REVIEW OF THE IMPLEMENTATION OF THE PLAN FOR THE NATIONWIDE ROLLOUT OF ANTIRETROVIRAL THERAPY IN ZIMBABWE

Implementation of PrEP in Kenya

ESPA Directorate KPI Report: Quarter 1,

By 20 February 2018 (midnight South African time). Proposals received after the date and time will not be accepted for consideration.

Global AIDS Response Progress Report Myanmar. National AIDS Programme

Objectives Measurable Indicators Means of Verification Important Assumptions Goal To promote an inclusive society where

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

Improving access of migrant populations to HIV Services in the Caribbean 09/ /2013

IMPACT AND OUTCOME INDICATORS IN THE NATIONAL HIV MONITORING AND EVALUATION FRAMEWORK

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

GLOBAL AIDS MONITORING REPORT

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

AN ACTIVITY-BASED COSTING TOOL

An overview of the NASA

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement

INDIA UNCT GENDER SCORECARD ASSESSMENT UNCT Performance Indicators for Gender Equality and Women s Empowerment

Report to the Merton Clinical Commissioning Group Governing Body

January. 12 Components Monitoring and Evaluation System Strengthening Tool

Models of good practice in drug treatment in Europe. Project group

International technical guidance on sexuality education

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Treat All : From Policy to Action - What will it take?

Promoting hepatitis B vaccination

WPR/RC68/7 page 7 ANNEX

WHO Strategy and Goals for Viral Hepatitis Elimination

Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective

UNAIDS 2018 Guidance. Frequently Asked Questions

Services and Support Information Leaflet

Version for the Silent Procedure 29 April Agenda item January Hepatitis

Re Advertised TERMS OF REFERENCE NATIONAL INDIVIDUAL CONSULTANT - HIV AND AIDS, HUMAN RIGHTS AND THE LAW

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

REGIONAL CSO MEETING REPORT GEF EXPANDED CONSTITUENCY WORKSHOP (ECW)

Programme Analyst Adolescents and Youth. Duty Station: The Gambia. DHR Director Date: August 2017

Updated Resource Requirements for Sustainable Financing of the HIV Response in Indonesia

Harms and harm reduction workbook. Country X

TERMS OF REFERENCE FOR INDIVIDUAL LOCAL CONSULTANCY

Application of M&E System Strengthening Tool (MESST) to assess the M&E systems for HIV prevention and treatment programme in Sri Lanka

Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia

Monitoring and Evaluation. What Is Monitoring & Evaluation? Principles and purposes of monitoring, evaluation and reporting

The Strategy Development Process. Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015

Hepatitis prevention in the context of HIV prevention point work in Latvia

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Primary Health Networks Drug and Alcohol Treatment Services Funding. Updated Activity Work Plan : Drug and Alcohol Treatment

POLIO POST-CERTIFICATION STRATEGY. Summary overview 8 August 2017

EG on Prison Health Third Meeting Paris France June 2007

TERMS OF REFERENCE FOR INDIVIDUAL LOCAL CONSULTANCY. Consultant to Evaluate and Review the National Condom Strategy

TB/HIV Care s Experience Setting up PrEP Sites and Engaging Potential Service Users. John Mutsambi and Peggy Modikoe TB/HIV Care

About Project Sunrise

UNSD Questionnaire on National Gender Statistics Programs and Activities *

The HIV Prevention England programme: what s next? Cary James May 2016

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Terms of Reference. Technical Specialist, Reproductive, Maternal, Child and Adolescent Health (RMNCAH) Official Job Title: Grade (Classified) P-4

Health Situation Room. Introduction to the Concept 2018

COUNTRY TABLE. MONTENEGRO.

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

TERMS OF REFERENCE Review of the National South African Sex Worker HIV Plan

2016 NYC Hep B Coalition Work Plan

Cross-cutting HSS (Health Systems Strengthening): Experience from WPRO

TERMS OF REFERENCE INTEGRATED TB/HIV PROJECT, Thyolo, Malawi - FINAL EVALUATION. August 2017

INDIVIDUAL CONSULTANT PROCUREMENT NOTICE

Summary. Project title: HIV/AIDS and Tuberculosis Control Project Cooperation scheme: Technical Cooperation Total cost:approximately 452 million yen

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

SADC HIV AND AIDS Work Plan 2012/13

New Jersey Department of Human Services Quarterly Newsletter Division of Mental Health Services June 2006

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

ViiV Healthcare s Position on Prevention in HIV

Transcription:

GUIDE: Reporting Template_HIV Narrative Report Section Contract Number Project Title Contract Period Reporting Period Reporting Date (dd/mm/yyyy) Explanation project start and end date in (DD/MM/YYYY) format 1. GENERAL SITUATION (For this reporting period) A brief overview describing developments & main experiences, and a discussion on any significant or unexpected changes or events relevant to your programme (No more than 00 words). GOOD PRACTICES AND CHALLENGES/CONSTRAINTS (For this reporting period) A note on what did and did not work well, also specific difficulties encountered and what strategies were developed to adjust implementation.1 GOOD PRACTICES: (Key achievements and A list on key achievements and related approaches which worked for achievements. approaches that worked well). CHALLENGES/CONSTRAINTS/DIFFICULTIES: A list on difficulties encountered and strategies/actions undertaken to address these issues.. PRESSING ISSUES (For this reporting period) The actions which are needed from MDG Fund to help your programme/your work. Annex B_Core Indicators Section Disease Reporting period Explanation Indicator The indicators are aligned with project logical framework. Target Target figures are pre-filled in the relevant cells. Those figures (number or %)are taken from latest version of Logical Frame sheet submitted priorily and approved by MDG FMO. Achievement The achieved figures are needed to fill under this column. The information for age and sex disaggregation are requested for relevant indicators. % Achieved MDG added the formula to calculate percentage of achievement against the targets. Reasons for programmatic deviation and any other A note on why under-achieve or over-achieve during the reporting period. comments Annex C_Achieved by township Section Disease Reporting period State/Region and Township Needle + Syringes Condom Explanation The township list is same as proposed township area and MDG will fill this information according to signed description of action document. The number mentioned in this annex C townships must be consistent with Annex B achieved results. How many needle and syringes distributed for this township? Fill out only the achievement figures for this reporting period How many condom distributed for this township? Fill out only the achievement figures for this reporting period AEI Report

MDG FUND TECHNICAL REPORT Contract Number Project Title Contract Period Reporting Period Reporting Date (dd/mm/yyyy) From: To: 1. GENERAL SITUATION (For this reporting period) A brief overview describing developments & main experiences, and a discussion on any significant or unexpected changes or events relevant to your programme (No more than 00 words) 1.1 Main Experiences (No more than 00 words) 1. Significant and/or unexpected changes (No more than 00 words). GOOD PRACTICES AND CHALLENGES/CONSTRAINTS (For this reporting period) (A note on what did and did not work well, also specific difficulties encountered and what strategies were developed to adjust implementation).1 GOOD PRACTICES: (Key achievements and approaches that worked well) Sr. 1 5 7 8 9 10 Key Achievements Approaches (Why it worked?)

. CHALLENGES/CONSTRAINTS/DIFFICULTIES: (Difficulties encountered and strategies/actions undertaken to address these issues) Sr. 1 Challenges/Constraints/Difficulties Actions taken Additional comments 5 7 8 9 10. PRESSING ISSUES (For this reporting period) What actions are needed from the MDG Fund to help your work?

Revised at May 01 Annex B: Core Indicators (Fill out only those which are relevant for your project) Disease Reporting period: 0 HIV 0 ID 1 5 Number of prisoners reached with HIV prevention programmes 7 Number of condoms distributed for free to drug users 8 Number of condoms distributed for free to prisoners 9 Number of condoms distributed for free to people living with HIV 10 11 Return rate of used injecting equipment (needle and syringe) 1 1 INDICATOR Number of people who inject drugs reached with HIV prevention programmes (Outreach) Number of people who inject drugs reached with HIV prevention programmes (DIC) Number of drug users reached with HIV prevention programmes (Outreach) Number of drug users reached with HIV prevention programmes (DIC) Number of condoms distributed for free to people who inject drugs Number of sterile injecting equipment distributed to people who inject drugs Number of people who inject drugs who received an HIV test and known the result Number of drug users who received an HIV test and known the result TARGET ACHIEVEMENT Total TARGET Male Female Male Female Total Achieved % Achieved Reasons for programmatic deviation and any other comments

Revised at May 01 1 15 Number of people who inject drugs who received STI treatment 1 Number of drug users who received STI treatment 17 Number of prisoners who received STI treatment 18 Number of drug users receiving methadone maintenance therapy 19 0 Number of drug users who received hepatitis B virus (HBV) test 1 5 Number of prisoners who received an HIV test and known the result Number of people who inject drugs who received hepatitis B virus (HBV) test Number of people who inject drugs who were vaccinated with rapid schedule for Hepatitis B infection Number of drug users who were vaccinated with rapid schedule for Hepatitis B infection Percentage of adults and children with HIV known to be on treatment 1 months after initiating ART Number of adults with advanced HIV infection receiving antiretroviral therapy (disaggregated by sex) Number of children (<15 yrs) in need provided with ART (disaggregated by sex) Number of people living with HIV receiving Cotrimoxazole prophylaxis who are not on ART (disaggregated by sex) * Comments (if any) on the figures reported: 5

Annex C: Township wise Report (Fill out only the achievement figures for this reporting period) Disease Reporting period: HIV 0 0 Sr. State/Region Township Needle + Syringes Condom Remark 1 5 7 8 9

ACCOUNTABILITY, EQUITY AND INCLUSION (AEI) AND CONFLICT SENSITIVITY (CS) REPORT 0 Township Contract Number 0 Contract Period Reporting Period 0 From: 0-Jan-00 To: 0-Jan-00 Reporting Date (dd/mm/yyyy) Do you have an AEI Focal Point? For how long? 1 KEY AEI & CS ACTIVITIES implemented by the AEI Focal Point or the Organization Please provide details in the below table including key achievements and challenges. (for this reporting period) No Description Brief comments on implementation Achievements Challenges 1.1 Organizational Commitments on AEI & CS (e.g. AEI and CS related policies including gender mainstreaming, staff code of conduct, written principles of stakeholder inclusion and nondiscrimination, etc ) 1. Staff Capacity Building (e.g. six monthly capacity building plan on AEI + CS, etc...) 1. 1. Sharing Information (e.g. quarterly meetings or other methods to share appropriate information about the organization and its activities with all relevant stakeholders including beneficiaries, etc...) Participation (e.g.ongoing comprehensive stakeholder participation at different stages of the project, examples and records that input is affecting programme/project decisions, etc ) 1.5 Learning and Continual Improvement (e.g. regular monitoring of progress on AEI and CS issues and learning/reflection based on results, such as workshops, etc ) 1. Social Inclusion (e.g. organisation has ongoing routine consultation meetings with CSOs and all key stakeholders, etc...) 1.7 Project Community Feedback (number) (Total number of feedback received and responded to. How did you respond and when?) 1.8 Project Community Feedback (issues) (Identify the top five issues raised through feedback mechanism e.g. relevant to project, organization, advocacy to relevant authority, MDG Fund and others) Version V01_AEI, July 01. 7 HIV-Reporting-Template-Master

1.9 Strengthening local partner capacity (if you have local partner(s), please explain how you have strengthened their capacities in the past six months). KEY LESSONS LEARNED (for this reporting period) Please provide AEI & CS key lessons learned (No more than 500 words) Version V01_AEI, July 01. 8 HIV-Reporting-Template-Master